Ledipasvir crystal form and preparation method thereof
AssigneeShanghai Forefront Pharmaceutical Co., Ltd.
InventorsWei Li, Yi Ren, Chengjun Huang, Yanyan Zhu, Shaojun Fu, Gang Fu, Zhewen Wei
Life of this patent
Estimating the term…
Loading patent…
AssigneeShanghai Forefront Pharmaceutical Co., Ltd.
InventorsWei Li, Yi Ren, Chengjun Huang, Yanyan Zhu, Shaojun Fu, Gang Fu, Zhewen Wei
Estimating the term…
The present invention relates to a novel Ledipasvir (LDV) crystal form and a preparation method thereof. Specifically, disclosed is an LDV solvate. The solvate is a solvate formed by LDV and a solvent A and/or a solvent B, wherein the solvent A is acetonitrile or acetone; and the solvent B is methyl tertiary butyl ether (MTBE). Also disclosed are a preparation method and an application of the solvate. The solvate has a high purity, a good crystallization property, and better optical stability. The preparation method is simple and the process is stable. The solvate can significantly improve quality control and industrial applications of LDV-containing drugs.
A Ledipasvir solvate, wherein which is a solvate of LDV formed with component A and component B, wherein the component A is acetonitrile or acetone, and the component B is methyl tert-butyl ether (MTBE);
Dependencies are inferred from the claim text.